Valeo Financial Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History

Valeo Financial Advisors’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50	Closed	–	–	617
2021 Q1	$0	Hold	50	–	–	﹤0.01%	2013
2020 Q4	$0	Hold	50	–	–	﹤0.01%	1673
2020 Q3	$0	Hold	50	–	–	﹤0.01%	1607
2020 Q2	$1K	Hold	50	–	–	﹤0.01%	1845
2020 Q1	$0	Sell	50 -1,000	-95%	-$7.1K	﹤0.01%	1788
2019 Q4	$7K	Hold	1,050	–	–	﹤0.01%	1185
2019 Q3	$7K	Hold	1,050	–	–	﹤0.01%	1104
2019 Q2	$8K	Hold	1,050	–	–	﹤0.01%	1069
2019 Q1	$15K	Hold	1,050	–	–	﹤0.01%	853
2018 Q4	$12K	Hold	1,050	–	–	﹤0.01%	826
2018 Q3	$19K	Hold	1,050	–	–	﹤0.01%	784
2018 Q2	$19K	Hold	1,050	–	–	﹤0.01%	774
2018 Q1	$12K	Buy	1,050 +1,000	+2,000%	+$17K	﹤0.01%	871
2017 Q4	$1K	Hold	50	–	–	﹤0.01%	1248
2017 Q3	$1K	Buy	+50	New	+$1.1K	﹤0.01%	1073

Other funds holding ATNM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Valeo Financial Advisors's ATNM Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Actinium Pharmaceuticals (ATNM) in Q2 2021, closing a stake of 50 shares.

Valeo Financial Advisors first reported a position in ATNM in Q3 2017 and held it in 15 quarters. The position peaked at $19K in Q3 2018. 37 funds tracked by Wall St. Rank hold ATNM as of Q2 2021.

Valeo Financial Advisors reported no remaining Actinium Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Valeo Financial Advisors sold 50 Actinium Pharmaceuticals shares in Q2 2021.
Valeo Financial Advisors first reported a position in Actinium Pharmaceuticals in Q3 2017 and held it in 15 quarters.
Valeo Financial Advisors's Actinium Pharmaceuticals position peaked at $19K in Q3 2018.
37 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.